Forecast on the Nutraceuticals Industry: An Overview for 2024-2025

We sought insights from industry experts deeply versed in marketplace dynamics to discuss significant trends and developments in business, regulation, science, and the market that the industry should focus on in the upcoming year. Their insights span a range of issues, including state regulations, global supply chain strategies, and women’s health.

Michael McGuffin, President of the American Herbal Products Association (AHPA), highlighted the external pressures on the industry at both state and federal levels. He emphasized the importance of the industry uniting to capitalize on opportunities with the new government to underscore the unique role of dietary supplements in health support. AHPA is advocating for legislative changes to empower the FDA to act against illegal products disguised as dietary supplements, enhancing consumer protection and industry integrity.

The industry faces challenges, including state efforts to limit access to dietary supplements, potentially invigorated by changes in federal power. The year 2025 is seen as pivotal for reinforcing commitments to safety, transparency, and consumer protection, necessitating collaboration and proactive engagement from all stakeholders.

Duffy MacKay, Senior VP at the Consumer Healthcare Products Association (CHPA), reflected on past FDA warnings about health risks from products marketed as dietary supplements but containing active drug ingredients. He discussed significant legal actions and regulatory responses to fraudulent products, highlighting the ongoing challenges of ensuring product quality and safety in the face of diverse retail standards.

Michael McGuffin stressed the need for legislative support to differentiate legitimate supplements from illegal products and to combat restrictive state regulations. The industry aims to leverage the new political landscape to enhance the recognition and regulation of dietary supplements, promoting consumer health and industry growth.

Steve Mister, President and CEO of the Council for Responsible Nutrition (CRN), discussed the evolution of the Dietary Supplement Health and Education Act (DSHEA) and the need for updates to reflect current market conditions without compromising the law’s core principles. He advocated for practical reforms to enhance FDA enforcement and industry transparency.

Karen Howard, CEO of the Organic & Natural Health Association, outlined their focus on integrity, access, and innovation in regulatory, business, and scientific areas. She emphasized the importance of improved testing methods and transparency to ensure product quality and consumer trust.

Loren Israelsen, President of the United Natural Products Alliance (UNPA), discussed the significant changes expected from political shifts and regulatory reforms under new leadership. He highlighted the potential impacts on industry practices and regulatory approaches, emphasizing the need for a balanced and effective regulatory framework.

Jim Emme, CEO of NOW Health Group, reported strong growth and improvements in supply chain management but noted ongoing challenges with transportation costs and regulatory compliance. He stressed the importance of maintaining consumer trust through rigorous product testing and compliance with quality standards.

Karen E. Todd, VP at Kyowa Hakko USA, noted a shift in consumer preferences towards scientifically validated ingredients, reflecting a broader demand for transparency and efficacy in health products.

Shaheen Majeed, Global CEO of Sabinsa Corporation, discussed the complexities of global pesticide testing standards and the importance of diversity in clinical research to address specific health needs and regional differences.

The insights from these industry leaders underscore the dynamic nature of the dietary supplement market and the critical need for strategic collaboration, regulatory clarity, and consumer-focused innovation to navigate the challenges and opportunities ahead.